25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ATRY (Atrys Health SL) Stock Analysis
Buy, Hold or Sell?

Let's analyze Atrys Health SL together

I guess you are interested in Atrys Health SL. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Atrys Health SL’s Financial Insights
  • 📈 Technical Analysis (TA) – Atrys Health SL’s Price Targets

I'm going to help you getting a better view of Atrys Health SL. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Atrys Health SL

I send you an email if I find something interesting about Atrys Health SL.

1. Quick Overview

1.1. Quick analysis of Atrys Health SL (30 sec.)










1.2. What can you expect buying and holding a share of Atrys Health SL? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€3.34
Expected worth in 1 year
€1.41
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
€-1.93
Return On Investment
-68.5%

For what price can you sell your share?

Current Price per Share
€2.82
Expected price per share
€2.8 - €3.07
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Atrys Health SL (5 min.)




Live pricePrice per Share (EOD)
€2.82
Intrinsic Value Per Share
€-2.79 - €-2.23
Total Value Per Share
€0.54 - €1.10

2.2. Growth of Atrys Health SL (5 min.)




Is Atrys Health SL growing?

Current yearPrevious yearGrowGrow %
How rich?$297.3m$340.3m-$43m-14.5%

How much money is Atrys Health SL making?

Current yearPrevious yearGrowGrow %
Making money-$37.3m-$53.5m$16.2m43.5%
Net Profit Margin-14.9%-22.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Atrys Health SL (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#191 / 856

Most Revenue
#50 / 856

Most Profit
#725 / 856

Most Efficient
#347 / 856
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Atrys Health SL?

Welcome investor! Atrys Health SL's management wants to use your money to grow the business. In return you get a share of Atrys Health SL.

First you should know what it really means to hold a share of Atrys Health SL. And how you can make/lose money.

Speculation

The Price per Share of Atrys Health SL is €2.82. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Atrys Health SL.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Atrys Health SL, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €3.34. Based on the TTM, the Book Value Change Per Share is €-0.48 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.63 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Atrys Health SL.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.49-17.4%-0.49-17.4%-0.71-25.0%-0.52-18.4%-0.40-14.2%-0.20-7.0%
Usd Book Value Change Per Share-0.57-20.1%-0.57-20.1%-0.74-26.2%-0.11-3.8%0.6623.4%0.3813.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.57-20.1%-0.57-20.1%-0.74-26.2%-0.11-3.8%0.6623.4%0.3813.5%
Usd Price Per Share3.96-3.96-4.31-5.18-7.58-5.09-
Price to Earnings Ratio-8.05--8.05--6.11--11.47--37.86-1,581.96-
Price-to-Total Gains Ratio-6.98--6.98--5.84--1.81-3.51-18.78-
Price to Book Ratio1.01-1.01-0.96-1.12-3.03-4.62-
Price-to-Total Gains Ratio-6.98--6.98--5.84--1.81-3.51-18.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.310962
Number of shares302
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.570.66
Usd Total Gains Per Share-0.570.66
Gains per Quarter (302 shares)-171.16199.26
Gains per Year (302 shares)-684.64797.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-685-6950797787
20-1369-1380015941584
30-2054-2065023912381
40-2739-2750031883178
50-3423-3435039853975
60-4108-4120047824772
70-4792-4805055795569
80-5477-5490063766366
90-6162-6175071737163
100-6846-6860079717960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%7.06.00.053.8%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%11.02.00.084.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%11.02.00.084.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Atrys Health SL compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.483-0.4830%-0.628+30%-0.091-81%0.562-186%0.325-249%
Book Value Per Share--3.3363.3360%3.819-13%3.867-14%3.241+3%1.773+88%
Current Ratio--0.8940.8940%0.973-8%0.964-7%1.215-26%1.614-45%
Debt To Asset Ratio--0.5670.5670%0.539+5%0.542+4%0.543+4%0.527+7%
Debt To Equity Ratio--1.3081.3080%1.170+12%1.189+10%1.193+10%1.147+14%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---45858432.000-45858432.0000%-18365512.000-60%24843912.000-285%237323781.000-119%216770861.431-121%
Eps---0.419-0.4190%-0.601+43%-0.442+6%-0.341-19%-0.168-60%
Ev To Ebitda Ratio---2.405-2.4050%-0.575-76%1.788-234%43.413-106%62.156-104%
Ev To Sales Ratio---0.216-0.2160%-0.091-58%0.145-249%4.721-105%12.902-102%
Free Cash Flow Per Share---0.134-0.1340%-0.188+40%-0.241+81%-0.173+29%-0.103-23%
Free Cash Flow To Equity Per Share---0.285-0.2850%-0.080-72%0.160-278%0.270-205%0.177-261%
Gross Profit Margin--1.0001.0000%1.017-2%1.017-2%1.037-4%1.018-2%
Intrinsic Value_10Y_max---2.232----------
Intrinsic Value_10Y_min---2.794----------
Intrinsic Value_1Y_max---0.184----------
Intrinsic Value_1Y_min---0.254----------
Intrinsic Value_3Y_max---0.583----------
Intrinsic Value_3Y_min---0.790----------
Intrinsic Value_5Y_max---1.019----------
Intrinsic Value_5Y_min---1.351----------
Market Cap214056048.000-20%255804568.000255804568.0000%278576488.000-8%335000245.333-24%490203531.200-48%329275890.688-22%
Net Profit Margin---0.149-0.1490%-0.226+51%-0.167+12%-0.151+1%-0.028-81%
Operating Margin---0.047-0.0470%0.011-522%-0.029-39%-0.036-24%0.076-162%
Operating Ratio--1.0501.0500%1.009+4%1.020+3%1.021+3%0.931+13%
Pb Ratio0.845-20%1.0101.0100%0.961+5%1.122-10%3.029-67%4.621-78%
Pe Ratio-6.737+16%-8.051-8.0510%-6.110-24%-11.465+42%-37.859+370%1581.959-101%
Price Per Share2.820-20%3.3703.3700%3.670-8%4.413-24%6.458-48%4.338-22%
Price To Free Cash Flow Ratio-21.108+16%-25.225-25.2250%-19.562-22%-20.056-20%-72.028+186%-70.250+178%
Price To Total Gains Ratio-5.842+16%-6.981-6.9810%-5.841-16%-1.807-74%3.511-299%18.780-137%
Quick Ratio--0.9120.9120%0.841+8%0.892+2%1.140-20%1.501-39%
Return On Assets---0.054-0.0540%-0.072+33%-0.053-2%-0.043-22%-0.016-71%
Return On Equity---0.126-0.1260%-0.157+25%-0.117-6%-0.093-26%-0.033-74%
Total Gains Per Share---0.483-0.4830%-0.628+30%-0.091-81%0.562-186%0.325-249%
Usd Book Value--297330258.100297330258.1000%340350456.200-13%344675057.867-14%288829193.390+3%157993988.856+88%
Usd Book Value Change Per Share---0.567-0.5670%-0.738+30%-0.107-81%0.660-186%0.381-249%
Usd Book Value Per Share--3.9173.9170%4.484-13%4.541-14%3.805+3%2.081+88%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---53842385.011-53842385.0110%-21562947.639-60%29169237.079-285%278641851.272-119%254510668.406-121%
Usd Eps---0.491-0.4910%-0.705+43%-0.519+6%-0.400-19%-0.198-60%
Usd Free Cash Flow---11906548.100-11906548.1000%-16720358.100+40%-21516165.233+81%-15389152.603+29%-9168130.967-23%
Usd Free Cash Flow Per Share---0.157-0.1570%-0.220+40%-0.283+81%-0.203+29%-0.121-23%
Usd Free Cash Flow To Equity Per Share---0.335-0.3350%-0.094-72%0.188-278%0.317-205%0.208-261%
Usd Market Cap251323205.957-20%300340143.289300340143.2890%327076654.561-8%393323788.046-24%575547965.982-48%386602823.257-22%
Usd Price Per Share3.311-20%3.9573.9570%4.309-8%5.182-24%7.582-48%5.093-22%
Usd Profit---37305853.400-37305853.4000%-53527219.000+43%-39462283.733+6%-29597684.055-21%-14638907.431-61%
Usd Revenue--249781556.300249781556.3000%236662162.900+6%235331124.867+6%176987693.971+41%92672770.277+170%
Usd Total Gains Per Share---0.567-0.5670%-0.738+30%-0.107-81%0.660-186%0.381-249%
 EOD+3 -5MRQTTM+0 -0YOY+18 -203Y+12 -265Y+10 -2810Y+7 -31

3.3 Fundamental Score

Let's check the fundamental score of Atrys Health SL based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.737
Price to Book Ratio (EOD)Between0-10.845
Net Profit Margin (MRQ)Greater than0-0.149
Operating Margin (MRQ)Greater than0-0.047
Quick Ratio (MRQ)Greater than10.912
Current Ratio (MRQ)Greater than10.894
Debt to Asset Ratio (MRQ)Less than10.567
Debt to Equity Ratio (MRQ)Less than11.308
Return on Equity (MRQ)Greater than0.15-0.126
Return on Assets (MRQ)Greater than0.05-0.054
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Atrys Health SL based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.703
Ma 20Greater thanMa 502.847
Ma 50Greater thanMa 1002.870
Ma 100Greater thanMa 2002.811
OpenGreater thanClose2.830
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Atrys Health SL

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests. It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.

Fundamental data was last updated by Penke on 2025-08-22 06:51:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Atrys Health SL earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • A Net Profit Margin of -14.9% means that €-0.15 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Atrys Health SL:

  • The MRQ is -14.9%. The company is making a huge loss. -2
  • The TTM is -14.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14.9%TTM-14.9%0.0%
TTM-14.9%YOY-22.6%+7.7%
TTM-14.9%5Y-15.1%+0.2%
5Y-15.1%10Y-2.8%-12.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.9%-88.2%+73.3%
TTM-14.9%-154.3%+139.4%
YOY-22.6%-209.9%+187.3%
3Y-16.7%-277.1%+260.4%
5Y-15.1%-353.0%+337.9%
10Y-2.8%-512.7%+509.9%
4.3.1.2. Return on Assets

Shows how efficient Atrys Health SL is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • -5.4% Return on Assets means that Atrys Health SL generated €-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Atrys Health SL:

  • The MRQ is -5.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.4%TTM-5.4%0.0%
TTM-5.4%YOY-7.2%+1.8%
TTM-5.4%5Y-4.3%-1.2%
5Y-4.3%10Y-1.6%-2.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.4%-11.9%+6.5%
TTM-5.4%-11.9%+6.5%
YOY-7.2%-11.1%+3.9%
3Y-5.3%-11.9%+6.6%
5Y-4.3%-11.6%+7.3%
10Y-1.6%-13.6%+12.0%
4.3.1.3. Return on Equity

Shows how efficient Atrys Health SL is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • -12.6% Return on Equity means Atrys Health SL generated €-0.13 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Atrys Health SL:

  • The MRQ is -12.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.6%TTM-12.6%0.0%
TTM-12.6%YOY-15.7%+3.2%
TTM-12.6%5Y-9.3%-3.3%
5Y-9.3%10Y-3.3%-6.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.6%-14.0%+1.4%
TTM-12.6%-14.7%+2.1%
YOY-15.7%-15.1%-0.6%
3Y-11.7%-16.4%+4.7%
5Y-9.3%-17.0%+7.7%
10Y-3.3%-19.0%+15.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Atrys Health SL.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Atrys Health SL is operating .

  • Measures how much profit Atrys Health SL makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • An Operating Margin of -4.7% means the company generated €-0.05  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Atrys Health SL:

  • The MRQ is -4.7%. The company is operating very inefficient. -2
  • The TTM is -4.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-4.7%TTM-4.7%0.0%
TTM-4.7%YOY1.1%-5.8%
TTM-4.7%5Y-3.6%-1.1%
5Y-3.6%10Y7.6%-11.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.7%-164.9%+160.2%
TTM-4.7%-253.9%+249.2%
YOY1.1%-238.7%+239.8%
3Y-2.9%-257.0%+254.1%
5Y-3.6%-342.8%+339.2%
10Y7.6%-504.1%+511.7%
4.3.2.2. Operating Ratio

Measures how efficient Atrys Health SL is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.05 means that the operating costs are €1.05 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Atrys Health SL:

  • The MRQ is 1.050. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.050. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.050TTM1.0500.000
TTM1.050YOY1.009+0.040
TTM1.0505Y1.021+0.028
5Y1.02110Y0.931+0.090
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0501.934-0.884
TTM1.0502.761-1.711
YOY1.0092.982-1.973
3Y1.0203.739-2.719
5Y1.0214.724-3.703
10Y0.9316.833-5.902
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Atrys Health SL.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Atrys Health SL is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.89 means the company has €0.89 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Atrys Health SL:

  • The MRQ is 0.894. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.894. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.894TTM0.8940.000
TTM0.894YOY0.973-0.080
TTM0.8945Y1.215-0.321
5Y1.21510Y1.614-0.399
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8943.458-2.564
TTM0.8943.710-2.816
YOY0.9734.102-3.129
3Y0.9644.591-3.627
5Y1.2155.731-4.516
10Y1.6146.150-4.536
4.4.3.2. Quick Ratio

Measures if Atrys Health SL is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • A Quick Ratio of 0.91 means the company can pay off €0.91 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Atrys Health SL:

  • The MRQ is 0.912. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.912. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.912TTM0.9120.000
TTM0.912YOY0.841+0.071
TTM0.9125Y1.140-0.228
5Y1.14010Y1.501-0.362
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9122.946-2.034
TTM0.9123.290-2.378
YOY0.8413.905-3.064
3Y0.8924.381-3.489
5Y1.1405.804-4.664
10Y1.5016.522-5.021
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Atrys Health SL.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Atrys Health SL assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Atrys Health SL to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.57 means that Atrys Health SL assets are financed with 56.7% credit (debt) and the remaining percentage (100% - 56.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Atrys Health SL:

  • The MRQ is 0.567. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.567. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.567TTM0.5670.000
TTM0.567YOY0.539+0.027
TTM0.5675Y0.543+0.024
5Y0.54310Y0.527+0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5670.340+0.227
TTM0.5670.356+0.211
YOY0.5390.333+0.206
3Y0.5420.342+0.200
5Y0.5430.349+0.194
10Y0.5270.378+0.149
4.5.4.2. Debt to Equity Ratio

Measures if Atrys Health SL is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • A Debt to Equity ratio of 130.8% means that company has €1.31 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Atrys Health SL:

  • The MRQ is 1.308. The company is able to pay all its debts with equity. +1
  • The TTM is 1.308. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.308TTM1.3080.000
TTM1.308YOY1.170+0.138
TTM1.3085Y1.193+0.115
5Y1.19310Y1.147+0.046
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3080.393+0.915
TTM1.3080.439+0.869
YOY1.1700.428+0.742
3Y1.1890.461+0.728
5Y1.1930.464+0.729
10Y1.1470.515+0.632
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Atrys Health SL generates.

  • Above 15 is considered overpriced but always compare Atrys Health SL to the Biotechnology industry mean.
  • A PE ratio of -8.05 means the investor is paying €-8.05 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Atrys Health SL:

  • The EOD is -6.737. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.051. Based on the earnings, the company is expensive. -2
  • The TTM is -8.051. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.737MRQ-8.051+1.314
MRQ-8.051TTM-8.0510.000
TTM-8.051YOY-6.110-1.940
TTM-8.0515Y-37.859+29.808
5Y-37.85910Y1,581.959-1,619.817
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.737-2.578-4.159
MRQ-8.051-2.362-5.689
TTM-8.051-2.670-5.381
YOY-6.110-3.698-2.412
3Y-11.465-3.737-7.728
5Y-37.859-6.230-31.629
10Y1,581.959-6.859+1,588.818
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Atrys Health SL:

  • The EOD is -21.108. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -25.225. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -25.225. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.108MRQ-25.225+4.117
MRQ-25.225TTM-25.2250.000
TTM-25.225YOY-19.562-5.663
TTM-25.2255Y-72.028+46.803
5Y-72.02810Y-70.250-1.777
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-21.108-3.369-17.739
MRQ-25.225-3.033-22.192
TTM-25.225-3.836-21.389
YOY-19.562-4.278-15.284
3Y-20.056-5.132-14.924
5Y-72.028-8.331-63.697
10Y-70.250-9.556-60.694
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Atrys Health SL is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.01 means the investor is paying €1.01 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Atrys Health SL:

  • The EOD is 0.845. Based on the equity, the company is cheap. +2
  • The MRQ is 1.010. Based on the equity, the company is underpriced. +1
  • The TTM is 1.010. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.845MRQ1.010-0.165
MRQ1.010TTM1.0100.000
TTM1.010YOY0.961+0.049
TTM1.0105Y3.029-2.019
5Y3.02910Y4.621-1.592
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8452.244-1.399
MRQ1.0101.989-0.979
TTM1.0102.206-1.196
YOY0.9612.419-1.458
3Y1.1222.558-1.436
5Y3.0293.711-0.682
10Y4.6214.441+0.180
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets584,194
Total Liabilities330,953
Total Stockholder Equity253,098
 As reported
Total Liabilities 330,953
Total Stockholder Equity+ 253,098
Total Assets = 584,194

Assets

Total Assets584,194
Total Current Assets89,180
Long-term Assets495,014
Total Current Assets
Cash And Cash Equivalents 20,365
Short-term Investments 8,925
Net Receivables 52,821
Inventory 1,570
Other Current Assets 5,499
Total Current Assets  (as reported)89,180
Total Current Assets  (calculated)89,180
+/-0
Long-term Assets
Property Plant Equipment 58,167
Goodwill 267,352
Intangible Assets 156,739
Long-term Assets Other 8,925
Long-term Assets  (as reported)495,014
Long-term Assets  (calculated)491,183
+/- 3,831

Liabilities & Shareholders' Equity

Total Current Liabilities99,788
Long-term Liabilities231,165
Total Stockholder Equity253,098
Total Current Liabilities
Short-term Debt 14,336
Short Long Term Debt 14,336
Accounts payable 25,360
Other Current Liabilities 52,988
Total Current Liabilities  (as reported)99,788
Total Current Liabilities  (calculated)107,020
+/- 7,232
Long-term Liabilities
Long term Debt 151,789
Long-term Liabilities Other 25,995
Long-term Liabilities  (as reported)231,165
Long-term Liabilities  (calculated)177,784
+/- 53,381
Total Stockholder Equity
Common Stock760
Retained Earnings -31,774
Other Stockholders Equity 284,112
Total Stockholder Equity (as reported)253,098
Total Stockholder Equity (calculated)253,098
+/-0
Other
Capital Stock760
Cash and Short Term Investments 29,290
Common Stock Shares Outstanding 75,652
Liabilities and Stockholders Equity 584,194
Net Debt 145,760
Net Invested Capital 419,223
Net Working Capital -10,608
Property Plant and Equipment Gross 58,167
Short Long Term Debt Total 166,125



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
18,294
18,871
19,530
26,095
30,569
40,197
53,693
88,043
175,776
565,632
705,281
629,001
584,194
584,194629,001705,281565,632175,77688,04353,69340,19730,56926,09519,53018,87118,294
   > Total Current Assets 
4,764
3,688
2,978
3,481
7,006
13,400
15,500
18,026
37,264
103,106
103,105
100,870
89,180
89,180100,870103,105103,10637,26418,02615,50013,4007,0063,4812,9783,6884,764
       Cash And Cash Equivalents 
454
691
448
915
2,850
9,268
9,763
8,329
17,476
35,126
34,295
41,829
20,365
20,36541,82934,29535,12617,4768,3299,7639,2682,850915448691454
       Short-term Investments 
2,795
308
50
50
179
142
151
439
129
5,441
1,549
348
8,925
8,9253481,5495,44112943915114217950503082,795
       Net Receivables 
1,335
562
2,303
2,389
2,721
3,368
3,717
8,289
16,985
54,295
55,301
44,626
52,821
52,82144,62655,30154,29516,9858,2893,7173,3682,7212,3892,3035621,335
       Inventory 
180
180
177
174
181
208
259
271
655
793
1,213
1,677
1,570
1,5701,6771,213793655271259208181174177180180
   > Long-term Assets 
13,530
15,184
16,552
22,614
23,564
26,797
38,193
70,017
138,512
462,526
602,176
528,131
495,014
495,014528,131602,176462,526138,51270,01738,19326,79723,56422,61416,55215,18413,530
       Property Plant Equipment 
2,255
930
739
3,170
2,755
2,571
2,648
5,738
9,843
62,538
69,331
62,479
58,167
58,16762,47969,33162,5389,8435,7382,6482,5712,7553,1707399302,255
       Goodwill 
0
0
0
2,341
1,744
1,550
10,095
35,460
95,051
235,836
306,212
275,740
267,352
267,352275,740306,212235,83695,05135,46010,0951,5501,7442,341000
       Intangible Assets 
7,387
9,565
10,898
12,236
13,649
15,177
17,009
19,542
26,482
151,132
212,690
174,745
156,739
156,739174,745212,690151,13226,48219,54217,00915,17713,64912,23610,8989,5657,387
       Long-term Assets Other 
426
413
416
632
759
1,751
2,656
4,046
988
8,378
4,130
5,250
8,925
8,9255,2504,1308,3789884,0462,6561,751759632416413426
> Total Liabilities 
12,236
12,253
12,609
14,396
16,306
16,899
27,250
48,089
100,448
291,653
367,708
339,119
330,953
330,953339,119367,708291,653100,44848,08927,25016,89916,30614,39612,60912,25312,236
   > Total Current Liabilities 
1,006
888
602
3,169
4,369
4,966
5,480
9,819
21,410
71,502
100,563
103,642
99,788
99,788103,642100,56371,50221,4109,8195,4804,9664,3693,1696028881,006
       Short-term Debt 
230
342
110
1,629
3,200
1,161
2,990
5,027
11,965
21,709
30,739
64,311
14,336
14,33664,31130,73921,70911,9655,0272,9901,1613,2001,629110342230
       Short Long Term Debt 
0
0
0
0
0
1,143
2,904
3,787
11,082
15,518
23,364
57,869
14,336
14,33657,86923,36415,51811,0823,7872,9041,14300000
       Accounts payable 
326
112
239
435
967
970
798
1,786
4,255
16,041
15,686
19,136
25,360
25,36019,13615,68616,0414,2551,786798970967435239112326
       Other Current Liabilities 
450
434
253
941
-426
3,096
1,262
1,950
3,654
24,235
48,683
20,005
52,988
52,98820,00548,68324,2353,6541,9501,2623,096-426941253434450
   > Long-term Liabilities 
11,230
11,366
12,007
12,639
11,937
11,933
21,771
38,270
79,038
220,151
267,145
235,477
231,165
231,165235,477267,145220,15179,03838,27021,77111,93311,93712,63912,00711,36611,230
       Long term Debt Total 
0
0
0
0
0
0
6,420
5,411
10,077
0
0
0
0
000010,0775,4116,420000000
       Other Liabilities 
0
0
0
0
1,647
6,539
6,767
8,081
28,609
41,283
56,730
0
0
0056,73041,28328,6098,0816,7676,5391,6470000
       Deferred Long Term Liability 
0
0
0
0
12,933
14,193
15,447
16,284
22,622
23,521
24,835
0
0
0024,83523,52122,62216,28415,44714,19312,9330000
> Total Stockholder Equity
6,058
6,618
6,921
10,287
14,263
23,298
26,443
39,954
75,328
274,030
337,630
289,872
253,098
253,098289,872337,630274,03075,32839,95426,44323,29814,26310,2876,9216,6186,058
   Common Stock
4
4
4
66
112
176
216
256
347
614
760
760
760
76076076061434725621617611266444
   Retained Earnings 
682
337
320
1,295
63
97
12
-105
-2,015
-23,255
-23,259
-45,590
-31,774
-31,774-45,590-23,259-23,255-2,015-1051297631,295320337682
   Capital Surplus 
0
0
0
0
0
0
24,959
38,426
78,079
0
0
0
0
000078,07938,42624,959000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
5,372
2,630
2,630
8,927
17,119
21,584
26,226
39,803
83,573
316,371
488,189
246,841
284,112
284,112246,841488,189316,37183,57339,80326,22621,58417,1198,9272,6302,6305,372



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue212,743
Cost of Revenue-67,359
Gross Profit145,384145,384
 
Operating Income (+$)
Gross Profit145,384
Operating Expense-155,935
Operating Income-10,551-10,551
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense155,9350
 
Net Interest Income (+$)
Interest Income469
Interest Expense-23,496
Other Finance Cost-0
Net Interest Income-23,027
 
Pretax Income (+$)
Operating Income-10,551
Net Interest Income-23,027
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-33,47012,368
EBIT - interestExpense = -33,470
-33,398
-8,278
Interest Expense23,496
Earnings Before Interest and Taxes (EBIT)-9,974-9,974
Earnings Before Interest and Taxes (EBITDA)19,070
 
After tax Income (+$)
Income Before Tax-33,470
Tax Provision--1,624
Net Income From Continuing Ops-31,846-31,846
Net Income-31,774
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses223,294
Total Other Income/Expenses Net-22,91923,027
 

Technical Analysis of Atrys Health SL
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Atrys Health SL. The general trend of Atrys Health SL is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Atrys Health SL's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Atrys Health SL Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Atrys Health SL.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.95 < 2.95 < 3.07.

The bearish price targets are: 2.8 > 2.8 > 2.8.

Know someone who trades $ATRY? Share this with them.👇

Atrys Health SL Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Atrys Health SL. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Atrys Health SL Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Atrys Health SL. The current macd is -0.0086658.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Atrys Health SL price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Atrys Health SL. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Atrys Health SL price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Atrys Health SL Daily Moving Average Convergence/Divergence (MACD) ChartAtrys Health SL Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Atrys Health SL. The current adx is 13.00.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Atrys Health SL shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Atrys Health SL Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Atrys Health SL. The current sar is 3.0026703.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Atrys Health SL Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Atrys Health SL. The current rsi is 47.70. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Atrys Health SL Daily Relative Strength Index (RSI) ChartAtrys Health SL Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Atrys Health SL. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Atrys Health SL price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Atrys Health SL Daily Stochastic Oscillator ChartAtrys Health SL Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Atrys Health SL. The current cci is -94.72743521.

Atrys Health SL Daily Commodity Channel Index (CCI) ChartAtrys Health SL Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Atrys Health SL. The current cmo is -6.64724925.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Atrys Health SL Daily Chande Momentum Oscillator (CMO) ChartAtrys Health SL Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Atrys Health SL. The current willr is -78.125.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Atrys Health SL is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Atrys Health SL Daily Williams %R ChartAtrys Health SL Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Atrys Health SL.

Atrys Health SL Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Atrys Health SL. The current atr is 0.07248458.

Atrys Health SL Daily Average True Range (ATR) ChartAtrys Health SL Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Atrys Health SL. The current obv is 1,665,340.

Atrys Health SL Daily On-Balance Volume (OBV) ChartAtrys Health SL Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Atrys Health SL. The current mfi is 38.10.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Atrys Health SL Daily Money Flow Index (MFI) ChartAtrys Health SL Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Atrys Health SL.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-08-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-08-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-08-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Atrys Health SL Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Atrys Health SL based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.703
Ma 20Greater thanMa 502.847
Ma 50Greater thanMa 1002.870
Ma 100Greater thanMa 2002.811
OpenGreater thanClose2.830
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Atrys Health SL with someone you think should read this too:
  • Are you bullish or bearish on Atrys Health SL? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Atrys Health SL? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Atrys Health SL

I send you an email if I find something interesting about Atrys Health SL.


Comments

How you think about this?

Leave a comment

Stay informed about Atrys Health SL.

Receive notifications about Atrys Health SL in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.